'ASCUS, rule out HSIL'

Cytologic features, histologic correlates, and human papillomavirus detection

Mark E. Sherman, Sana O. Tabbara, David R. Scott, Robert J. Kurman, Andrew G. Glass, M. Michele Manos, Robert D. Burk, Brenda B. Rush, Mark Schiffman

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Risk factors, cytologic and histopathologic features, and human papillomavirus (HPV) detection associated with 75 cervical smears classified as atypical squamous cells of undetermined significance, rule out high-grade squamous intraepithelial lesion (ASCUS, rule out HSIL) were reviewed. Cases were identified in a pathology panel review of material collected from 1953 women participating in a 5-year prospective study of HPV infection and squamous intraepithelial lesions at Kaiser Permanente, Portland, Oregon, sponsored by the National Cancer Institute. Initial abnormal smears diagnosed as ASCUS, rule out HSIL by one panelist or diagnosed as ASCUS by one pathologist and as HSIL by another were included. The 75 ASCUS, rule out HSIL smears identified were examined again by two pathologists after the study. These cases were compared with cases of ASCUS, not otherwise specified (ASCUS, NOS) and HSIL identified in the same group of 1953 women. Findings in ASCUS, rule out HSIL included tissue fragments (21%); atypical immature metaplasia (17%); atypical mature metaplasia (15%); small atypical cells (9%); and atypical repair (4%). A final patient classification of HSIL, reflecting all available data, was assigned to 11 (24%) of 46 women with ASCUS, rule out HSIL and to 1(1%) of 80 women with ASCUS, NOS in the original review (P < .001). Detection of oncogenic HPV types at diagnosis in ASCUS, rule out HSIL; ASCUS, NOS; and HSIL was similar, but data were unavailable for many subjects. Among women not tested at diagnosis, enrollment testing (1 to 4 years earlier) revealed that HPV detection in women with ASCUS, rule out HSIL was intermediate in frequency between ASCUS, NOS and HSIL. These data suggest that ASCUS, rule out HSIL is a distinct diagnosis from ASCUS, NOS because it is more often associated with an underlying HSIL. Consequently, women with ASCUS, rule out HSIL should be referred for colposcopic examination.

Original languageEnglish (US)
Pages (from-to)335-343
Number of pages9
JournalModern Pathology
Volume12
Issue number4
StatePublished - Apr 1999

Fingerprint

Atypical Squamous Cells of the Cervix
Metaplasia
Vaginal Smears
Papillomavirus Infections
National Cancer Institute (U.S.)
Prospective Studies
Pathology
Pathologists
Squamous Intraepithelial Lesions of the Cervix

Keywords

  • ASCUS
  • Atypical squamous cells
  • Bethesda System
  • Cervix
  • Papillomavirus

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Sherman, M. E., Tabbara, S. O., Scott, D. R., Kurman, R. J., Glass, A. G., Manos, M. M., ... Schiffman, M. (1999). 'ASCUS, rule out HSIL': Cytologic features, histologic correlates, and human papillomavirus detection. Modern Pathology, 12(4), 335-343.

'ASCUS, rule out HSIL' : Cytologic features, histologic correlates, and human papillomavirus detection. / Sherman, Mark E.; Tabbara, Sana O.; Scott, David R.; Kurman, Robert J.; Glass, Andrew G.; Manos, M. Michele; Burk, Robert D.; Rush, Brenda B.; Schiffman, Mark.

In: Modern Pathology, Vol. 12, No. 4, 04.1999, p. 335-343.

Research output: Contribution to journalArticle

Sherman, ME, Tabbara, SO, Scott, DR, Kurman, RJ, Glass, AG, Manos, MM, Burk, RD, Rush, BB & Schiffman, M 1999, ''ASCUS, rule out HSIL': Cytologic features, histologic correlates, and human papillomavirus detection', Modern Pathology, vol. 12, no. 4, pp. 335-343.
Sherman ME, Tabbara SO, Scott DR, Kurman RJ, Glass AG, Manos MM et al. 'ASCUS, rule out HSIL': Cytologic features, histologic correlates, and human papillomavirus detection. Modern Pathology. 1999 Apr;12(4):335-343.
Sherman, Mark E. ; Tabbara, Sana O. ; Scott, David R. ; Kurman, Robert J. ; Glass, Andrew G. ; Manos, M. Michele ; Burk, Robert D. ; Rush, Brenda B. ; Schiffman, Mark. / 'ASCUS, rule out HSIL' : Cytologic features, histologic correlates, and human papillomavirus detection. In: Modern Pathology. 1999 ; Vol. 12, No. 4. pp. 335-343.
@article{1df3831939e04a5b8e6f40652834ab88,
title = "'ASCUS, rule out HSIL': Cytologic features, histologic correlates, and human papillomavirus detection",
abstract = "Risk factors, cytologic and histopathologic features, and human papillomavirus (HPV) detection associated with 75 cervical smears classified as atypical squamous cells of undetermined significance, rule out high-grade squamous intraepithelial lesion (ASCUS, rule out HSIL) were reviewed. Cases were identified in a pathology panel review of material collected from 1953 women participating in a 5-year prospective study of HPV infection and squamous intraepithelial lesions at Kaiser Permanente, Portland, Oregon, sponsored by the National Cancer Institute. Initial abnormal smears diagnosed as ASCUS, rule out HSIL by one panelist or diagnosed as ASCUS by one pathologist and as HSIL by another were included. The 75 ASCUS, rule out HSIL smears identified were examined again by two pathologists after the study. These cases were compared with cases of ASCUS, not otherwise specified (ASCUS, NOS) and HSIL identified in the same group of 1953 women. Findings in ASCUS, rule out HSIL included tissue fragments (21{\%}); atypical immature metaplasia (17{\%}); atypical mature metaplasia (15{\%}); small atypical cells (9{\%}); and atypical repair (4{\%}). A final patient classification of HSIL, reflecting all available data, was assigned to 11 (24{\%}) of 46 women with ASCUS, rule out HSIL and to 1(1{\%}) of 80 women with ASCUS, NOS in the original review (P < .001). Detection of oncogenic HPV types at diagnosis in ASCUS, rule out HSIL; ASCUS, NOS; and HSIL was similar, but data were unavailable for many subjects. Among women not tested at diagnosis, enrollment testing (1 to 4 years earlier) revealed that HPV detection in women with ASCUS, rule out HSIL was intermediate in frequency between ASCUS, NOS and HSIL. These data suggest that ASCUS, rule out HSIL is a distinct diagnosis from ASCUS, NOS because it is more often associated with an underlying HSIL. Consequently, women with ASCUS, rule out HSIL should be referred for colposcopic examination.",
keywords = "ASCUS, Atypical squamous cells, Bethesda System, Cervix, Papillomavirus",
author = "Sherman, {Mark E.} and Tabbara, {Sana O.} and Scott, {David R.} and Kurman, {Robert J.} and Glass, {Andrew G.} and Manos, {M. Michele} and Burk, {Robert D.} and Rush, {Brenda B.} and Mark Schiffman",
year = "1999",
month = "4",
language = "English (US)",
volume = "12",
pages = "335--343",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - 'ASCUS, rule out HSIL'

T2 - Cytologic features, histologic correlates, and human papillomavirus detection

AU - Sherman, Mark E.

AU - Tabbara, Sana O.

AU - Scott, David R.

AU - Kurman, Robert J.

AU - Glass, Andrew G.

AU - Manos, M. Michele

AU - Burk, Robert D.

AU - Rush, Brenda B.

AU - Schiffman, Mark

PY - 1999/4

Y1 - 1999/4

N2 - Risk factors, cytologic and histopathologic features, and human papillomavirus (HPV) detection associated with 75 cervical smears classified as atypical squamous cells of undetermined significance, rule out high-grade squamous intraepithelial lesion (ASCUS, rule out HSIL) were reviewed. Cases were identified in a pathology panel review of material collected from 1953 women participating in a 5-year prospective study of HPV infection and squamous intraepithelial lesions at Kaiser Permanente, Portland, Oregon, sponsored by the National Cancer Institute. Initial abnormal smears diagnosed as ASCUS, rule out HSIL by one panelist or diagnosed as ASCUS by one pathologist and as HSIL by another were included. The 75 ASCUS, rule out HSIL smears identified were examined again by two pathologists after the study. These cases were compared with cases of ASCUS, not otherwise specified (ASCUS, NOS) and HSIL identified in the same group of 1953 women. Findings in ASCUS, rule out HSIL included tissue fragments (21%); atypical immature metaplasia (17%); atypical mature metaplasia (15%); small atypical cells (9%); and atypical repair (4%). A final patient classification of HSIL, reflecting all available data, was assigned to 11 (24%) of 46 women with ASCUS, rule out HSIL and to 1(1%) of 80 women with ASCUS, NOS in the original review (P < .001). Detection of oncogenic HPV types at diagnosis in ASCUS, rule out HSIL; ASCUS, NOS; and HSIL was similar, but data were unavailable for many subjects. Among women not tested at diagnosis, enrollment testing (1 to 4 years earlier) revealed that HPV detection in women with ASCUS, rule out HSIL was intermediate in frequency between ASCUS, NOS and HSIL. These data suggest that ASCUS, rule out HSIL is a distinct diagnosis from ASCUS, NOS because it is more often associated with an underlying HSIL. Consequently, women with ASCUS, rule out HSIL should be referred for colposcopic examination.

AB - Risk factors, cytologic and histopathologic features, and human papillomavirus (HPV) detection associated with 75 cervical smears classified as atypical squamous cells of undetermined significance, rule out high-grade squamous intraepithelial lesion (ASCUS, rule out HSIL) were reviewed. Cases were identified in a pathology panel review of material collected from 1953 women participating in a 5-year prospective study of HPV infection and squamous intraepithelial lesions at Kaiser Permanente, Portland, Oregon, sponsored by the National Cancer Institute. Initial abnormal smears diagnosed as ASCUS, rule out HSIL by one panelist or diagnosed as ASCUS by one pathologist and as HSIL by another were included. The 75 ASCUS, rule out HSIL smears identified were examined again by two pathologists after the study. These cases were compared with cases of ASCUS, not otherwise specified (ASCUS, NOS) and HSIL identified in the same group of 1953 women. Findings in ASCUS, rule out HSIL included tissue fragments (21%); atypical immature metaplasia (17%); atypical mature metaplasia (15%); small atypical cells (9%); and atypical repair (4%). A final patient classification of HSIL, reflecting all available data, was assigned to 11 (24%) of 46 women with ASCUS, rule out HSIL and to 1(1%) of 80 women with ASCUS, NOS in the original review (P < .001). Detection of oncogenic HPV types at diagnosis in ASCUS, rule out HSIL; ASCUS, NOS; and HSIL was similar, but data were unavailable for many subjects. Among women not tested at diagnosis, enrollment testing (1 to 4 years earlier) revealed that HPV detection in women with ASCUS, rule out HSIL was intermediate in frequency between ASCUS, NOS and HSIL. These data suggest that ASCUS, rule out HSIL is a distinct diagnosis from ASCUS, NOS because it is more often associated with an underlying HSIL. Consequently, women with ASCUS, rule out HSIL should be referred for colposcopic examination.

KW - ASCUS

KW - Atypical squamous cells

KW - Bethesda System

KW - Cervix

KW - Papillomavirus

UR - http://www.scopus.com/inward/record.url?scp=0032905894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032905894&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 335

EP - 343

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 4

ER -